https://www.ndtvprofit.com/quarterly-earnings/dr-reddys-q2-results-impairment-charges-higher-raw-material-costs-hurt-profit?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
The Hyderabad-based drugmaker reported impairment charges of Rs 78 crore towards non-current assets.